Neurocrine Biosciences | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.29B 562M 2025-03
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
ALKERMES USD 171.7M 24.71M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amgen USD 1.69B 191M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Cytokinetics USD 62.34M 5.69M 2024-12
Dynavax Technologies USD 41.58M 1.48M 2024-12
Exelixis USD 134.33M 22.53M 2025-01
Gilead Sciences USD 1.26B 603M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Prothena USD 16.85M 88K 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Repligen USD 71.26M 10.93M 2025-03
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Neurocrine Biosciences Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.